624 results on '"Kashuba, Angela D M"'
Search Results
2. Application of infrared matrix-assisted laser desorption electrospray ionization mass spectrometry for morphine imaging in brain tissue
3. Ultra-long-acting in-situ forming implants with cabotegravir protect female macaques against rectal SHIV infection
4. Feasibility, Acceptability, and Preliminary Efficacy of a Gamified Mobile Health Contingency Management Intervention for PrEP Adherence Among Black MSM
5. Pharmacokinetic Modeling to Guide Preclinical Development of an Islatravir-Eluting Reservoir-Style Biodegradable Implant for Long-Acting HIV PrEP
6. Correction to: Feasibility, Acceptability, and Preliminary Efficacy of a Gamified Mobile Health Contingency Management Intervention for PrEP Adherence Among Black MSM
7. Deep analysis of CD4 T cells in the rhesus CNS during SIV infection
8. A multicompartment population PK model to predict tenofovir and emtricitabine mucosal tissue concentrations for HIV prevention
9. CCR5 inhibitor as novel acute graft versus host disease prophylaxis in children and young adults undergoing allogeneic stem cell transplant: results of the phase II study
10. CD4 T cell Responses in the CNS during SIV infection
11. Pharmacology of Drug Resistance
12. HIV-1 Tat and opioids act independently to limit antiretroviral brain concentrations and reduce blood–brain barrier integrity
13. Evaluation of Digital Image Recognition Methods for Mass Spectrometry Imaging Data Analysis
14. Development and validation of an LC-MS/MS assay for the quantification of dolutegravir extracted from human hair
15. Mass spectrometry imaging of hair identifies daily maraviroc adherence in HPTN 069/ACTG A5305
16. Dose-Ranging Plasma and Genital Tissue Pharmacokinetics and Biodegradation of Ultra-Long-Acting Cabotegravir In Situ Forming Implant
17. HIV-1-RNA Decay and Dolutegravir Concentrations in Semen of Patients Starting a First Antiretroviral Regimen
18. Using Real-Time Adherence Feedback to Enhance Communication About Adherence to Antiretroviral Therapy: Patient and Clinician Perspectives
19. A Translational Pharmacology Approach to Predicting Outcomes of Preexposure Prophylaxis Against HIV in Men and Women Using Tenofovir Disoproxil Fumarate With or Without Emtricitabine
20. Ultra-long-acting tunable biodegradable and removable controlled release implants for drug delivery
21. Leveraging physiologically based pharmacokinetic modeling to optimize dosing for lopinavir/ritonavir with rifampin in pediatric patients.
22. Ultra-long-acting removable drug delivery system for HIV treatment and prevention
23. Mechanisms of Drug Interactions I: Absorption, Metabolism, and Excretion
24. Quantitative Imaging Analysis of the Spatial Relationship between Antiretrovirals, Reverse Transcriptase Simian-Human Immunodeficiency Virus RNA, and Fibrosis in the Spleens of Nonhuman Primates
25. Sensitive Tenofovir Resistance Screening of HIV-1 From the Genital and Blood Compartments of Women With Breakthrough Infections in the CAPRISA 004 Tenofovir Gel Trial
26. Doravirine Concentrations and Human Immunodeficiency Virus Type 1 RNA in the Genital Fluids of Virologically Suppressed Adults Switching to Doravirine Plus Emtricitabine/Tenofovir Alafenamide
27. Leveraging Physiologically‐Based Pharmacokinetic ( PBPK ) Modeling to Optimize Dosing for Lopinavir/Ritonavir with Rifampin in Pediatric Patients
28. Mass Spectroscopy Imaging of Hair Strands Captures Short-Term and Long-Term Changes in Emtricitabine Adherence
29. Antiretroviral drug exposure in lymph nodes is heterogeneous and drug dependent
30. Randomized Pharmacokinetic Crossover Study Comparing 2 Curcumin Preparations in Plasma and Rectal Tissue of Healthy Human Volunteers
31. Accuracy of Self-Report and Pill-Count Measures of Adherence in the FEM-PrEP Clinical Trial: Implications for Future HIV-Prevention Trials
32. Quantitative mass spectrometry imaging of emtricitabine in cervical tissue model using infrared matrix-assisted laser desorption electrospray ionization
33. Effects of Injection Volume and Route of Administration on Dolutegravir In Situ Forming Implant Pharmacokinetics
34. Intracellular islatravir pharmacology differs between species in an in vitro model: implications for preclinical study design
35. Mapping Antiretroviral Drugs in Tissue by IR-MALDESI MSI Coupled to the Q Exactive and Comparison with LC-MS/MS SRM Assay
36. Single and Multiple Dose Pharmacokinetics of Maraviroc in Saliva, Semen, and Rectal Tissue of Healthy HIV–Negative Men
37. CYP2B6 Variants and Plasma Efavirenz Concentrations during Antiretroviral Therapy in Port-au-Prince, Haiti
38. Pharmacokinetics of Antiretrovirals in Genital Secretions and Anatomic Sites of HIV Transmission: Implications for HIV Prevention
39. Measuring Adherence by Visual Inspection of Returned Empty Gel Applicators in the CAPRISA 004 Microbicide Trial
40. Clinical Pharmacokinetic, Pharmacodynamic and Drug-Interaction Profile of the Integrase Inhibitor Dolutegravir
41. Pharmacokinetic and Pharmacodynamic Investigation of Efavirenz in the Semen and Blood of Human Immunodeficiency Virus Type 1-Infected Men
42. A cross-species comparison of antiretroviral penetration into lymph nodes using novel physiologically based pharmacokinetic models
43. Nucleoside Analogues Achieve High Concentrations in Seminal Plasma: Relationship between Drug Concentration and Virus Burden
44. Pharmacokinetic Modelling of Efavirenz, Atazanavir, Lamivudine and Tenofovir in the Female Genital Tract of HIV-Infected Pre-Menopausal Women
45. Quantitative Imaging Analysis of the Spatial Relationship between Antiretrovirals, Reverse Transcriptase Simian-Human Immunodeficiency Virus RNA, and Collagen in the Mesenteric Lymph Nodes of Nonhuman Primates
46. Pregnancy-Related Hormones Increase UGT1A1-Mediated Labetalol Metabolism in Human Hepatocytes
47. Variability in drug metabolizing enzyme activity in HIV-infected patients
48. Expression of Six Drug Transporters in Vaginal, Cervical, and Colorectal Tissues: Implications for Drug Disposition in HIV Prevention
49. Drug Interactions with New and Investigational Antiretrovirals
50. The Lymph Node Reservoir: Physiology, HIV Infection, and Antiretroviral Therapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.